In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PET (positron emission tomography) beats SPECT (single photon emission computed tomography) as heart risk diagnostic

This article was originally published in Clinica

Executive Summary

Positron emission tomography (PET) scanning is more accurate, less invasive and more cost effective than single photon emission computed tomography (SPECT) imaging when used as the first tool to diagnose cardiac vessel blockages. So suggest the results of a trial conducted at the State University of New York, published in the July edition of the Journal of Nuclear Medicine. Lead researcher Dr Michael Merhige, clinical associate professor of nuclear medicine at the university, said that the researchers found a more than 50% decrease in the use of invasive coronary arteriography and coronary artery bypass grafting when PET was used as the first-line test.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts